Scientific Article
previous document  unige:29789  next document
add to browser collection

Leukocyte extravasation as a target for anti-inflammatory therapy - Which molecule to choose?

Schon, Michael P.
Girolomoni, G.
Griffiths, C.
Bos, J. D.
Thestrup-Pedersen, K.
Cavani, A.
Nestle, F.
show hidden authors show all authors [1 - 12]
Published in Experimental dermatology. 2005, vol. 14, no. 1, p. 70-80
Abstract In view of the central pathogenic importance of leukocyte extravasation in inflammatory skin diseases, therapeutic interference with this - surprisingly complex - process is clearly a promising new approach for treating these dermatoses. Despite some disappointments during the clinical use of these agents and despite their crippling price tag, the recent incorporation of biologicals that target defined molecular controls of leukocyte extravasation into dermatological and rheumatological practise, consequently, has greatly enriched our therapeutic options for battling major, chronic, inflammatory dermatoses such as psoriasis. However, the - as yet unresolved and still rather controversially discussed - critical question is: Which of the multiple steps that control leukocyte extravasation in the human system really offer the most promising, most pragmatic, and safest molecular targets for therapeutic intervention for which disease entity? The current debate intends to stimulate public and rational debate of this crucial issue, beyond the evident commercial interests that are touched by whatever stand one takes.
Keywords Anti-Inflammatory Agents/*therapeutic useApoptosis/drug effects/immunologyCell Adhesion/drug effects/immunologyCell Adhesion Molecules/drug effects/immunologyCell Movement/drug effects/immunologyDermatitis/*drug therapy/immunologyHumansImmunosuppressive Agents/therapeutic useInflammation/drug therapy/immunologyLeukocyte Rolling/drug effects/immunologyLeukocytes/*drug effects/immunologyLymphocyte Activation/drug effects/immunologyModels, AnimalModels, ImmunologicalSkin Diseases/*drug therapy/immunology
PMID: 15660923
Full text
(ISO format)
BOEHNCKE, Wolf-Henning et al. Leukocyte extravasation as a target for anti-inflammatory therapy - Which molecule to choose?. In: Experimental dermatology, 2005, vol. 14, n° 1, p. 70-80. doi: 10.1111/j.0906-6705.2005.290a.x

440 hits

0 download


Deposited on : 2013-09-20

Export document
Format :
Citation style :